The Psilomethoxin saga continues as lab testing, legal pressure, and public criticism deepen doubts about the Church of Psilomethoxin's claimed sacrament

Psilomethoxin remains a disputed and unverified substance at the center of a conflict involving the Church of Psilomethoxin, outside chemists, journalists, and regulators. The core issue is the church's claim that adding 5-MeO-DMT to psilocybin mushroom cultivation produces a novel sacrament, despite repeated skepticism from scientists and the absence of convincing analytical confirmation. Independent lab testing and expert criticism have intensified concerns about what members may actually be consuming, how the substance is being represented, and whether religious framing is being used to bypass scientific and legal scrutiny. The controversy also raises broader questions about consumer protection, harm reduction, and accountability in psychedelic communities when extraordinary pharmacological claims circulate without solid evidence. Legal threats, media attention, and ongoing public debate have turned psilomethoxin into a case study in how misinformation, spiritual authority, and underground drug culture can collide. The dispute matters beyond one organization because it highlights the need for transparent testing, clear labeling, and rigorous standards around novel psychedelic claims.